메뉴 건너뛰기




Volumn 110, Issue 4, 2007, Pages 788-792

Serotonin receptor 1A C(-1019)G polymorphism associated with premenstrual dysphoric disorder

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN 1A RECEPTOR;

EID: 34848840633     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000284448.73490.ac     Document Type: Article
Times cited : (30)

References (33)
  • 2
    • 34848866003 scopus 로고    scopus 로고
    • Diagnostic and statistical manual of mental disorders: DSM IV. 4th ed. Washington (DC): American Psychiatric Association; 1994.
    • Diagnostic and statistical manual of mental disorders: DSM IV. 4th ed. Washington (DC): American Psychiatric Association; 1994.
  • 4
    • 34848848158 scopus 로고    scopus 로고
    • Eriksson E, Humble M. Serotonin in psychiatric pathophysiology. A review of data from experimental and clinical research. In: Gershon S, Pohl R, editors. Biological basis of psychiatric treatment. Scarpignato C, Vesell ES, editors. Progress in basic and clinical pharmacology. 3. Basel (Switzerland): Karger; 1990. p. 66-119.
    • Eriksson E, Humble M. Serotonin in psychiatric pathophysiology. A review of data from experimental and clinical research. In: Gershon S, Pohl R, editors. Biological basis of psychiatric treatment. Scarpignato C, Vesell ES, editors. Progress in basic and clinical pharmacology. Vol 3. Basel (Switzerland): Karger; 1990. p. 66-119.
  • 5
    • 0035078366 scopus 로고    scopus 로고
    • The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: An animal model of premenstrual irritability?
    • Ho HP, Olsson M, Westberg L, Melke J, Eriksson E. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability? Neuropsychopharmacology 2001;24:502-10.
    • (2001) Neuropsychopharmacology , vol.24 , pp. 502-510
    • Ho, H.P.1    Olsson, M.2    Westberg, L.3    Melke, J.4    Eriksson, E.5
  • 6
    • 0034466506 scopus 로고    scopus 로고
    • A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria
    • Steinberg S, Annable L, Young SN, Liyanage N. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria. Adv Exp Med Biol 1999;467:85-8.
    • (1999) Adv Exp Med Biol , vol.467 , pp. 85-88
    • Steinberg, S.1    Annable, L.2    Young, S.N.3    Liyanage, N.4
  • 7
    • 0027933066 scopus 로고
    • Acute tryptophan depletion aggravates premenstrual syndrome
    • Menkes DB, Coates DC, Fawcett JP. Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord 1994;32:37-44.
    • (1994) J Affect Disord , vol.32 , pp. 37-44
    • Menkes, D.B.1    Coates, D.C.2    Fawcett, J.P.3
  • 8
    • 0023927046 scopus 로고
    • Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome
    • Ashby CR Jr, Carr LA, Cook CL, Steptoe MM, Franks DD. Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome. Biol Psychiatry 1988;24:225-33.
    • (1988) Biol Psychiatry , vol.24 , pp. 225-233
    • Ashby Jr, C.R.1    Carr, L.A.2    Cook, C.L.3    Steptoe, M.M.4    Franks, D.D.5
  • 9
    • 0026703766 scopus 로고
    • Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome
    • Steege JF, Stout AL, Knight DL, Nemeroff CB. Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome. Am J Obstet Gynecol 1992;167:168-72.
    • (1992) Am J Obstet Gynecol , vol.167 , pp. 168-172
    • Steege, J.F.1    Stout, A.L.2    Knight, D.L.3    Nemeroff, C.B.4
  • 11
    • 0034734709 scopus 로고    scopus 로고
    • Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
    • Dimmock PW, Wyatt KM, Jones PW, O'Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000;356:1131-6.
    • (2000) Lancet , vol.356 , pp. 1131-1136
    • Dimmock, P.W.1    Wyatt, K.M.2    Jones, P.W.3    O'Brien, P.M.4
  • 12
    • 0027997897 scopus 로고    scopus 로고
    • Leibenluft E, Fiero PL, Rubinow DR. Effects of the menstrual cycle on dependent variables in mood disorder research [published erratum appears in Arch Gen Psychiatry 1995;52:144]. Arch Gen Psychiatry 1994;51:761-81.
    • Leibenluft E, Fiero PL, Rubinow DR. Effects of the menstrual cycle on dependent variables in mood disorder research [published erratum appears in Arch Gen Psychiatry 1995;52:144]. Arch Gen Psychiatry 1994;51:761-81.
  • 14
    • 0026515597 scopus 로고
    • Structure and function of the brain serotonin system
    • Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev 1992;72:165-229.
    • (1992) Physiol Rev , vol.72 , pp. 165-229
    • Jacobs, B.L.1    Azmitia, E.C.2
  • 15
    • 0025652414 scopus 로고
    • Anatomy of the serotonergic system
    • Tork I. Anatomy of the serotonergic system. Ann N Y Acad Sci 1990;600:9-34.
    • (1990) Ann N Y Acad Sci , vol.600 , pp. 9-34
    • Tork, I.1
  • 16
    • 0032695774 scopus 로고    scopus 로고
    • A common C-1018G polymorphism in the human 5-HT1A receptor gene
    • Wu S, Comings DE. A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 1999;9:105-6.
    • (1999) Psychiatr Genet , vol.9 , pp. 105-106
    • Wu, S.1    Comings, D.E.2
  • 17
    • 0141758243 scopus 로고    scopus 로고
    • Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide
    • Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003;23:8788-99.
    • (2003) J Neurosci , vol.23 , pp. 8788-8799
    • Lemonde, S.1    Turecki, G.2    Bakish, D.3    Du, L.4    Hrdina, P.D.5    Bown, C.D.6
  • 18
    • 0028102141 scopus 로고
    • 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
    • Stahl S. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Psychopharmacol Bull 1994;30:39-43.
    • (1994) Psychopharmacol Bull , vol.30 , pp. 39-43
    • Stahl, S.1
  • 19
    • 33748582618 scopus 로고    scopus 로고
    • Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders
    • Yu YW, Tsai SJ, Liou YJ, Hong CJ, Chen TJ. Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. Eur Neuropsychopharmacol 2006;498-503.
    • (2006) Eur Neuropsychopharmacol , pp. 498-503
    • Yu, Y.W.1    Tsai, S.J.2    Liou, Y.J.3    Hong, C.J.4    Chen, T.J.5
  • 20
    • 31044444151 scopus 로고    scopus 로고
    • Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder
    • Hong CJ, Chen TJ, Yu YW, Tsai SJ. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 2006;6:27-33.
    • (2006) Pharmacogenomics J , vol.6 , pp. 27-33
    • Hong, C.J.1    Chen, T.J.2    Yu, Y.W.3    Tsai, S.J.4
  • 21
    • 10644271666 scopus 로고    scopus 로고
    • The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: Preliminary findings
    • Serretti A, Artioli P, Lorenzi C, Pirovano A, Tubazio V, Zanardi R. The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. Int J Neuropsychopharmacol 2004;7:453-60.
    • (2004) Int J Neuropsychopharmacol , vol.7 , pp. 453-460
    • Serretti, A.1    Artioli, P.2    Lorenzi, C.3    Pirovano, A.4    Tubazio, V.5    Zanardi, R.6
  • 22
    • 10644242682 scopus 로고    scopus 로고
    • Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response
    • Lemonde S, Du L, Bakish D, Hrdina P, Albert PR. Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacol 2004;7:501-6.
    • (2004) Int J Neuropsychopharmacol , vol.7 , pp. 501-506
    • Lemonde, S.1    Du, L.2    Bakish, D.3    Hrdina, P.4    Albert, P.R.5
  • 23
    • 0031715653 scopus 로고    scopus 로고
    • Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression
    • Kendler KS, Karkowski LM, Corey LA, Neale MC. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 1998;155:1234-40.
    • (1998) Am J Psychiatry , vol.155 , pp. 1234-1240
    • Kendler, K.S.1    Karkowski, L.M.2    Corey, L.A.3    Neale, M.C.4
  • 24
    • 0026576953 scopus 로고
    • Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: A population-based twin study
    • Kendler KS, Silberg JL, Neale MC, Kessler RC, Heath AC, Eaves LJ. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study. Psychol Med 1992;22:85-100.
    • (1992) Psychol Med , vol.22 , pp. 85-100
    • Kendler, K.S.1    Silberg, J.L.2    Neale, M.C.3    Kessler, R.C.4    Heath, A.C.5    Eaves, L.J.6
  • 25
    • 0026016406 scopus 로고
    • Firstborn adolescent daughters and mothers with and without premenstrual syndrome: A comparison
    • Wilson CA, Turner CW, Keye WR Jr. Firstborn adolescent daughters and mothers with and without premenstrual syndrome: a comparison. J Adolesc Health 1991;12:130-7.
    • (1991) J Adolesc Health , vol.12 , pp. 130-137
    • Wilson, C.A.1    Turner, C.W.2    Keye Jr., W.R.3
  • 26
    • 30644476862 scopus 로고    scopus 로고
    • Daily Record of Severity of Problems (DRSP): Reliability and validity
    • Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health 2006;9:41-9.
    • (2006) Arch Womens Ment Health , vol.9 , pp. 41-49
    • Endicott, J.1    Nee, J.2    Harrison, W.3
  • 27
    • 0346630012 scopus 로고    scopus 로고
    • Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia
    • Rothe C, Gutknecht L, Freitag C, Tauber R, Mossner R, Franke P, et al. Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int J Neuropsychopharmacol 2004;7:189-92.
    • (2004) Int J Neuropsychopharmacol , vol.7 , pp. 189-192
    • Rothe, C.1    Gutknecht, L.2    Freitag, C.3    Tauber, R.4    Mossner, R.5    Franke, P.6
  • 28
    • 0029002285 scopus 로고
    • Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group
    • Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, et al. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med 1995;332:1529-34.
    • (1995) N Engl J Med , vol.332 , pp. 1529-1534
    • Steiner, M.1    Steinberg, S.2    Stewart, D.3    Carter, D.4    Berger, C.5    Reid, R.6
  • 29
    • 1642527869 scopus 로고    scopus 로고
    • Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder
    • Freeman EW, Rickels K, Sondheimer SJ, Polansky M, Xiao S. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder. Am J Psychiatry 2004;161:343-51.
    • (2004) Am J Psychiatry , vol.161 , pp. 343-351
    • Freeman, E.W.1    Rickels, K.2    Sondheimer, S.J.3    Polansky, M.4    Xiao, S.5
  • 30
    • 0035987758 scopus 로고    scopus 로고
    • Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder
    • Pearlstein T, Yonkers KA. Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder. Expert Opin Pharmacother 2002;3:979-91.
    • (2002) Expert Opin Pharmacother , vol.3 , pp. 979-991
    • Pearlstein, T.1    Yonkers, K.A.2
  • 31
    • 17744397364 scopus 로고    scopus 로고
    • Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram
    • Arias B, Catalan R, Gasto C, Gutierrez B, Fananas L. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram. J Psychopharmacol 2005;19:166-72.
    • (2005) J Psychopharmacol , vol.19 , pp. 166-172
    • Arias, B.1    Catalan, R.2    Gasto, C.3    Gutierrez, B.4    Fananas, L.5
  • 32
    • 14944360703 scopus 로고    scopus 로고
    • A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans
    • David SP, Murthy NV, Rabiner EA, Munafo MR, Johnstone EC, Jacob R, et al. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 2005;25:2586-90.
    • (2005) J Neurosci , vol.25 , pp. 2586-2590
    • David, S.P.1    Murthy, N.V.2    Rabiner, E.A.3    Munafo, M.R.4    Johnstone, E.C.5    Jacob, R.6
  • 33
    • 33750313988 scopus 로고    scopus 로고
    • Serotonin transporter, tryptophan hydroxylase, and monoamine oxidase A gene polymorphisms in premenstrual dysphoric disorder
    • Magnay JL, Ismail KM, Chapman G, Cioni L, Jones PW, O'Brien S. Serotonin transporter, tryptophan hydroxylase, and monoamine oxidase A gene polymorphisms in premenstrual dysphoric disorder. Am J Obstet Gynecol 2006;195:1254-9.
    • (2006) Am J Obstet Gynecol , vol.195 , pp. 1254-1259
    • Magnay, J.L.1    Ismail, K.M.2    Chapman, G.3    Cioni, L.4    Jones, P.W.5    O'Brien, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.